Mass Homozygotes Accumulation in the NCI-60 Cancer Cell Lines As Compared to HapMap Trios, and Relation to Fragile Site Location

• Xiaoyang Ruan,

  Affiliations Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, Minnesota, United States of America, Laboratory of Molecular Pharmacology, National Cancer Institute, Bethesda, Maryland, United States of America

  ⨯
• Jean-Pierre A. Kocher,

  Affiliation Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, Minnesota, United States of America

  ⨯
• Yves Pommier,

  Affiliation Laboratory of Molecular Pharmacology, National Cancer Institute, Bethesda, Maryland, United States of America

  ⨯
• Hongfang Liu ,

  * E-mail: liu.hongfang@mayo.edu (HL); wcr@mail.nih.gov (WCR)

  Affiliations Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, Minnesota, United States of America, Laboratory of Molecular Pharmacology, National Cancer Institute, Bethesda, Maryland, United States of America

  ⨯
• William C. Reinhold

  * E-mail: liu.hongfang@mayo.edu (HL); wcr@mail.nih.gov (WCR)

  Affiliation Laboratory of Molecular Pharmacology, National Cancer Institute, Bethesda, Maryland, United States of America

  ⨯